Literature DB >> 25604582

Association between co-inhibitory molecule gene tagging single nucleotide polymorphisms and the risk of colorectal cancer in Chinese.

Jie Ge1, Lin Zhu, Junde Zhou, Guangxiao Li, Ye Li, Shuying Li, Zhiwei Wu, Jiesheng Rong, Huiping Yuan, Yanhong Liu, Qiang Chi, Daxun Piao, Yashuang Zhao, Binbin Cui.   

Abstract

PURPOSE: T lymphocyte immune responses are controlled by both co-stimulatory and co-inhibitory signaling through T cell co-receptors. Cytotoxic T lymphocyte antigen-4 (CTLA-4), programmed death 1 (PD-1) and B and T lymphocyte attenuator (BTLA) are all co-inhibitory molecules that negatively regulate the activation of T cells. In this study, we investigated the relationship between ten tagging SNPs in three co-inhibitory molecule genes and colorectal cancer (CRC).
METHODS: We conducted a hospital-based case-control study consisting of 601 cases with CRC and 627 CRC-free individuals from the Heilongjiang Province of China.
RESULTS: The rs7421861 CT genotype was significantly associated with the risk of colorectal cancer compared to the wild-type TT genotype (adjusted OR 1.314, 95% CI 1.012-1.706, P = 0.041). The rs2705535 TT genotype was associated with the risk of rectal cancer [OR 1.819 (1.093-3.027), P = 0.021]. There was statistical interaction between the PD-1/rs2227982 (CT + TT) genotypes and high seafood intake (>once/week), as well as the CTLA-4/rs231777 variant and high pungent food intake (>3 times/week). The AG + AA genotypes of CTLA-4/rs3087243 statistically and antagonistically interacted with soybeans, pork and alcohol intake and were associated with CRC risk. Analogously, BTLA/rs1844089 interacted with pork intake, PD-1/rs7421861 with beef and lamb consumption and PD-1/rs6710479 with barbecue consumption. Haplotype G-C-G-A-T-T-A was significantly associated with CRC risk (OR 1.221 P = 0.034).
CONCLUSIONS: These data indicate potential associations between BTLA and PD-1 polymorphisms and CRC susceptibility. Additionally, the three co-inhibitory molecule gene SNPs have environmental interactions associated with CRC risk.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25604582     DOI: 10.1007/s00432-015-1915-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  43 in total

1.  CTLA-4 blockade: unveiling immune regulation.

Authors:  Glenn Dranoff
Journal:  J Clin Oncol       Date:  2004-12-21       Impact factor: 44.544

2.  Polymorphisms in XRCC1 gene, alcohol drinking, and risk of colorectal cancer: a case-control study in Jiangsu Province of China.

Authors:  Chang-Ming Gao; Jian-Hua Ding; Su-Ping Li; Yan-Ting Liu; Hai-Xia Cao; Jian-Zhong Wu; Jin-Hai Tang; Kazuo Tajima
Journal:  Asian Pac J Cancer Prev       Date:  2014-01

3.  Molecular basis of T cell inactivation by CTLA-4.

Authors:  K M Lee; E Chuang; M Griffin; R Khattri; D K Hong; W Zhang; D Straus; L E Samelson; C B Thompson; J A Bluestone
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

4.  Structure of murine CTLA-4 and its role in modulating T cell responsiveness.

Authors:  D A Ostrov; W Shi; J C Schwartz; S C Almo; S G Nathenson
Journal:  Science       Date:  2000-10-27       Impact factor: 47.728

Review 5.  DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis.

Authors:  Philip J Brooks; Jacob A Theruvathu
Journal:  Alcohol       Date:  2005-04       Impact factor: 2.405

6.  Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.

Authors:  P M Marcus; R B Hayes; P Vineis; M Garcia-Closas; N E Caporaso; H Autrup; R A Branch; J Brockmöller; T Ishizaki; A E Karakaya; J M Ladero; S Mommsen; H Okkels; M Romkes; I Roots; N Rothman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-05       Impact factor: 4.254

7.  Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis.

Authors:  V A Kuznetsov; I A Makalkin; M A Taylor; A S Perelson
Journal:  Bull Math Biol       Date:  1994-03       Impact factor: 1.758

8.  CTLA-4 +49A>G polymorphism is associated with the risk but not with the progression of colorectal cancer in Chinese.

Authors:  Peng Qi; Can-ping Ruan; Hao Wang; Fei-guo Zhou; Xin-yun Xu; Xing Gu; Yun-peng Zhao; Tong-hai Dou; Chun-fang Gao
Journal:  Int J Colorectal Dis       Date:  2009-09-29       Impact factor: 2.571

Review 9.  CTLA-4: a key regulatory point in the control of autoimmune disease.

Authors:  Kenneth J Scalapino; David I Daikh
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

10.  Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population.

Authors:  Lihong Wang; Dalin Li; Zhenkun Fu; Heng Li; Wei Jiang; Dianjun Li
Journal:  BMC Cancer       Date:  2007-09-10       Impact factor: 4.430

View more
  15 in total

1.  The relationship between genetic polymorphisms in apolipoprotein E (ApoE) gene and osteonecrosis of the femoral head induced by steroid in Chinese Han population.

Authors:  Lin Yuan; Wei Li; Xianquan Wang; Guang Yang; Haiyang Yu; Shui Sun
Journal:  Genes Genomics       Date:  2017-11-01       Impact factor: 1.839

Review 2.  PD-1 and cancer: molecular mechanisms and polymorphisms.

Authors:  Arash Salmaninejad; Vahid Khoramshahi; Alireza Azani; Ehsan Soltaninejad; Saeed Aslani; Mohammad Reza Zamani; Masoud Zal; Abolfazl Nesaei; Sayed Mostafa Hosseini
Journal:  Immunogenetics       Date:  2017-06-22       Impact factor: 3.330

Review 3.  Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies.

Authors:  Wenjing Dong; Mancheng Gong; Zhirong Shi; Jianjun Xiao; Junkai Zhang; Jiewen Peng
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

Review 4.  The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis.

Authors:  Jie Zhang; Taiqiang Zhao; Chengjie Xu; Jiang Huang; Hua Yu
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

5.  Programmed death-1 polymorphisms is associated with risk of esophagogastric junction adenocarcinoma in the Chinese Han population: A case-control study involving 2,740 subjects.

Authors:  Weifeng Tang; Shuchen Chen; Yu Chen; Jihong Lin; Jiangbo Lin; Yafeng Wang; Chao Liu; Mingqiang Kang
Journal:  Oncotarget       Date:  2017-06-13

6.  Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies.

Authors:  Mohammad Hashemi; Shima Karami; Sahel Sarabandi; Abdolkarim Moazeni-Roodi; Andrzej Małecki; Saeid Ghavami; Emilia Wiechec
Journal:  Cancers (Basel)       Date:  2019-08-10       Impact factor: 6.639

7.  PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese Women: A Hospital-Based Observational Study.

Authors:  Hong-Tao Ren; Yi-Ming Li; Xi-Jing Wang; Hua-Feng Kang; Tian-Bo Jin; Xiao-Bin Ma; Xing-Han Liu; Meng Wang; Kang Liu; Peng Xu; Qing-Ling Yao; Zhi-Jun Dai
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

Review 8.  Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect.

Authors:  Julie Jacobs; Evelien Smits; Filip Lardon; Patrick Pauwels; Vanessa Deschoolmeester
Journal:  J Immunol Res       Date:  2015-10-29       Impact factor: 4.818

9.  Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.

Authors:  Lidia Karabon; Anna Partyka; Monika Jasek; Ewa Lech-Maranda; Olga Grzybowska-Izydorczyk; Agnieszka Bojarska-Junak; Edyta Pawlak-Adamska; Anna Tomkiewicz; Tadeusz Robak; Jacek Rolinski; Irena Frydecka
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-12-08       Impact factor: 4.291

10.  Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population.

Authors:  Kun Huang; Erqiang Hu; Wan Li; Junjie Lv; Yuehan He; Gui Deng; Jinling Xiao; Chengcheng Yang; Xinyu Zhao; Lina Chen; Xinyan Wang
Journal:  BMC Med Genet       Date:  2019-11-12       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.